Therefore, the increase in LF induced by both the kinase inhibitors in PANC-1 cells that we observed in the present study could be harnessed to sensitize and implement synergistic novel treatments with PD-L1 antibody with improved efficacy of immunotherapy for pancreatic cancers. The gene discussed is CD274; the disease is familial pancreatic carcinoma.